Vaccines Do Not Reduce the Risk of Severe COVID-19 Among Cancer Patients Receiving Certain Therapies
COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.
Latest News
MRI Is Best for Detecting Breast Cancer in Patients With Dense Breasts and Negative Mammography
MRI is the best supplemental imaging modality for detecting breast cancer in women with dense breasts and negative mammography, a meta-analysis suggests.
Second-Line Bevacizumab Provides No Benefit in Advanced Neuroendocrine Carcinoma
Adding bevacizumab to second-line chemotherapy does not improve survival in patients with advanced neuroendocrine carcinoma, a phase 2 study suggests.
Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose CT scan and mammography rates were below expected from March 2020 to February 2022.
PDE5i Use After Robotic Prostate Cancer Surgery Linked to Better Survival
Phosphodiesterase-5 inhibitor use after robotic prostate cancer surgery was associated with a 57% lower risk of death.
COVID-19 Vaccination Coverage Hits 76% Among Adults 60 Years and Older
By the end of 2022, a median of 76% of adults aged 60 years and older had completed a primary vaccine series.
At-Home Medication Errors May Be Common for Children With Leukemia, Lymphoma
Medication errors may be common in children with leukemia or lymphoma, and these errors can lead to serious harm, a new study suggests.
COVID-19 Vaccination Tied to Reduced COVID-19 Severity in Breast Cancer
COVID-19 vaccination was associated with a reduction in COVID-19 severity for European breast cancer patients from December 2020 to January 2022, researchers found.
Docetaxel Acts as Radiosensitizer in Head and Neck Cancer
Adding docetaxel to radiation improves outcomes for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase 2/3 trial suggests.
Trodelvy Approved for Pretreated HR+/HER2- Metastatic Breast Cancer
The approval was based on data from the phase 3 TROPiCS-02 study.
FACT-RNT: A PRO Tool for Prostate Cancer Patients on Radionuclide Therapy
Researchers have developed FACT-RNT, a patient-reported outcome tool for prostate cancer patients receiving radionuclide therapy.
COVID-19 Leading Cause of Death for US Children, Young People
COVID-19 was among the 10 leading causes of death in people aged 0 to 19 years from August 1, 2021, to July 31, 2022.
Researchers Call for More Scrutiny of Oncology Trial Reports Written by Medical Writers
Oncology trial reports written by medical writers are more likely to have surrogate endpoints as the primary endpoint.
ROS and Nerve-Sparing Radical Cystectomy May Be Underused in Women With Bladder Cancer
A survey of US urologic oncologists suggests that reproductive organ-sparing and nerve-sparing radical cystectomy may be underused in women with bladder cancer.
Treatment May Increase Risk of Colorectal Cancer in Hodgkin Lymphoma Survivors
Hodgkin lymphoma patients treated with subdiaphragmatic radiation and/or procarbazine have an increased risk of developing colorectal cancer, a study suggests.
Imaging Guidelines for NSCLC Patients Not Being Followed
Despite NCCN guidelines recommending FDG PET/CT, 43.6% of patients were imaged with CT alone.
Cancer Mortality Rates Increased for Older Patients With Diabetes
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
FDA Removes Requirement for Positive COVID-19 Test for Paxlovid, Lagevrio
A positive SARS-CoV-2 test result is no longer required to prescribe Paxlovid and Lagevrio.
Ultra-Processed Food Linked to Increased Risk of Cancer and Death
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Location of KIT Mutations Impacts Response to TKIs in Patients With GIST
The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
Loading... 
Loading...